CLNN Long Put Strategy
CLNN (Clene Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Clene Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the discovery, advancement, and market introduction of pioneering therapeutic agents utilizing clean-surfaced nanotechnology (CSN). CNM-Au8 stands as its flagship compound, currently under evaluation across a diverse range of clinical studies. This includes a pivotal Phase 2/3 study intended for regulatory submission in individuals battling amyotrophic lateral sclerosis (ALS). The company has successfully concluded a Phase 2 proof-of-concept trial for those with early manifestations of ALS. Furthermore, two open-label, investigator-blinded Phase 2 trials assessing brain energy metabolism have been finished. An ongoing Phase 2 trial is investigating CNM-Au8's potential to mitigate visual pathway deficits stemming from chronic optic neuropathy, aiming for remyelination in stable relapsing Multiple Sclerosis patients.
CLNN (Clene Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $52.0M, a beta of 0.97 versus the broader market, a 52-week range of 3.5-13.5, average daily share volume of 475K, a public-listing history dating back to 2018, approximately 78 full-time employees. These structural characteristics shape how CLNN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.97 places CLNN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long put on CLNN?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
CLNN snapshot
As of August 14, 2026, spot at $4.21, ATM IV 22.70%, IV rank 1.53%, expected move 6.51%. The long put on CLNN below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this long put structure on CLNN specifically: CLNN IV at 22.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a CLNN long put, with a market-implied 1-standard-deviation move of approximately 6.51% (roughly $0.27 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CLNN expiries trade a higher absolute premium for lower per-day decay. Position sizing on CLNN should anchor to the underlying notional of $4.21 per share and to the trader's directional view on CLNN stock.
CLNN long put setup
The CLNN long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CLNN at $4.21 on that close, the first option leg uses a $4.21 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CLNN chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CLNN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $4.21 | N/A |
CLNN long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
CLNN long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on CLNN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on CLNN
Long puts on CLNN hedge an existing long CLNN stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying CLNN exposure being hedged.
CLNN thesis for this long put
The market-implied 1-standard-deviation range for CLNN extends from approximately $3.94 on the downside to $4.48 on the upside. A CLNN long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long CLNN position with one put per 100 shares held. Current CLNN IV rank near 1.53% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CLNN at 22.70%. As a Healthcare name, CLNN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CLNN-specific events.
CLNN long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CLNN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CLNN alongside the broader basket even when CLNN-specific fundamentals are unchanged. Long-premium structures like a long put on CLNN are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CLNN chain quotes before placing a trade.
Frequently asked questions
- What is a long put on CLNN?
- A long put on CLNN is the long put strategy applied to CLNN (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With CLNN stock at $4.21 on the most recent close, the strikes shown on this page are snapped to the nearest listed CLNN chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are CLNN long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the CLNN long put priced from the end-of-day chain at a 30-day expiry (ATM IV 22.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CLNN long put?
- The breakeven for the CLNN long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CLNN market-implied 1-standard-deviation expected move in the same options snapshot is approximately 6.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on CLNN?
- Long puts on CLNN hedge an existing long CLNN stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying CLNN exposure being hedged.
- How does current CLNN implied volatility affect this long put?
- CLNN ATM IV is at 22.70% with IV rank near 1.53%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.